The Joint Corp (JYNT)

$12.09 0.01 (0.04%)

14:19 EDT JYNT Stock Quote Delayed 30 Minutes

JYNT Stock Earnings: Joint Misses EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Mar 7, 2024

JYNT stock results show that Joint missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Do Penny Stocks Ever Make Money? Here Are 7 Success Stories

7 Small-Cap Stocks to Buy for Big Results in 2022

7 A-Rated Healthcare Stocks to Buy for the Long Haul

More Articles

Volume:

Previous Close -

Market Cap 173.73M

PE Ratio -18.59

EPS -0.65

Volume (Avg. Vol.) 7,739

Day's Range $12.06 - $12.25

52-Week Range $7.31 - $16.48

Dividend & Yield N/A (N/A)

JYNT Stock Predictions, Articles, and The Joint Corp News

From InvestorPlace
From the Web

5 Triple A-Rated Stocks to Buy for October

By Louis Navellier and the InvestorPlace Research Staff Oct 13, 2021

Each of these stocks to buy for October earns a coveted triple-A rating in Portfolio Grader. Here are the important details about each.

7 Risk-Averse Stocks to Buy for a Fortified Portfolio

By Louis Navellier and the InvestorPlace Research Staff Sep 28, 2021

The market is doing well, but it always pays to have prudent picks in your portfolio. Here are seven of the best risk averse stocks to buy.

7 Triple A-Rated Stocks to Buy for the Second Half of 2021

By Louis Navellier and the InvestorPlace Research Staff Jun 29, 2021

The virtual economy has had quite a year but now the rest of the economy is reviving, and these top-rated stocks to buy will be big winners.

7 Healthcare Stocks to Buy for Changing Demographics

By Louis Navellier and the InvestorPlace Research Staff Jun 11, 2021

These seven healthcare stocks are in a good position to take off as baby boomers continue to age into retirement.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 25, 2021

We're back at it again with a look at the biggest pre-market stock movers for Tuesday and Chinese education stocks are on the move.

8 Small-Cap Stocks With Plenty of Cred

By Louis Navellier and the InvestorPlace Research Staff Mar 29, 2021

These eight small-cap stocks are affordable, and they can deliver significant returns, especially during an economic recovery.

10 of the Top Franchise Stocks to Buy Now

By Will Ashworth, InvestorPlace Contributor Jan 30, 2020

Entrepreneur magazine’s 2020 Franchise 500 was released in mid-January. Here are 10 of the top franchise stocks to buy now.

7 Next-Generation Healthcare Stocks to Buy

By Louis Navellier, Editor, Growth Investor Oct 3, 2019

These healthcare stocks are all worth a "buy" now. The healthcare sector will keep chugging along despite market volatility.

The Joint reports growth in 2023 operating metrics below 2022 level (NASDAQ:JYNT)

From Seeking Alpha Jan 11, 2024

The Joint (NASDAQ:JYNT) has reported increased system-wide sales of 12%, compared to 21% in 2022.

The Joint Corp. discloses 10% owner Bandera Partners increased holding (NASDAQ:JYNT)

From Seeking Alpha Sep 19, 2023

The Joint Corp. (JYNT) disclosed in an SEC filing dated Sept 18 that its 10% owner Bandera Partners LLC bought an aggregate of 77,436 company shares between Sept 14 and Sept...

The Joint Corp. expects an 18% topline jump for Q2 (NASDAQ:JYNT)

From Seeking Alpha Sep 14, 2023

The Joint (JYNT) gives out preliminary Q2 revenue and expects an 18% surge to $29.3M. Increased system-wide sales by 13%, to $120.1M. Reported system-wide comp sales of...

3 Health Companies with Healthy Insider Buying and Market Support

From MarketBeat Sep 1, 2023

Insiders and institutions are buying healthcare stocks like Movano, The Beauty Health Company, and The Joint Corp., all offering value.

Joint announces receipt of Nasdaq listing delinquency notice (NASDAQ:JYNT)

From Seeking Alpha Aug 28, 2023

Joint (JYNT) has received a notice from the Nasdaq stating that it is not in compliance with a certain listing rule, the company said Friday.The company is in noncompliance as a result...

Joint (JYNT) Gets a Buy from Maxim Group

From TipRanks Nov 5, 2022

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Joint (JYNT – Research Report) yesterday and set a price target of $36.00. The company’s...

ADVERTISEMENT